CMG Pharmaceutical Co., Ltd. (KOSDAQ: 058820)

CMG Pharmaceutical Revenue

CMG Pharmaceutical had revenue of 24.85B KRW in the quarter ending June 30, 2024, a decrease of -2.28%. This brings the company's revenue in the last twelve months to 93.19B, up 1.98% year-over-year. In the year 2023, CMG Pharmaceutical had annual revenue of 93.91B with 14.25% growth.

• Revenue (ttm): 93.19B
• Revenue Growth: +1.98%
• P/S Ratio: 3.05
• Revenue / Employee: 336.42M
• Employees: 277
• Market Cap: 284.73B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	93.91B	11.71B	14.25%
Dec 31, 2022	82.20B	23.57B	40.21%
Dec 31, 2019	58.62B	8.76B	17.56%
Dec 31, 2018	49.86B	8.33B	20.05%
Dec 31, 2017	41.54B	8.57B	25.98%